MyLeukemiaTeam

Are you curious about what the experience of being on Campath (alemtuzumab) is like?

Campath is a monoclonal antibody — basically a lab-made protein that helps your immune system target and destroy cancerous T cells. It's typically given through an IV, three times a week for several weeks.

Here are some key things to know Show Full Answer

Are you curious about what the experience of being on Campath (alemtuzumab) is like?

Campath is a monoclonal antibody — basically a lab-made protein that helps your immune system target and destroy cancerous T cells. It's typically given through an IV, three times a week for several weeks.

Here are some key things to know about the Campath experience:

- Effectiveness: It can lead to complete remission in around 90% of people, which is pretty remarkable
- It's not a cure: Relapse is common after treatment ends, so ongoing monitoring is important
- Infection risk: Because it affects your immune system, your body becomes more vulnerable to infections during and after treatment
- It may be combined: If complete remission isn't achieved with Campath alone, Nipent (pentostatin) is sometimes added to the regimen

After achieving remission, a stem cell transplant is often recommended to help reduce the chance of relapse — though not everyone is a candidate for that next step.

It's always worth having an open conversation with your care team about what to expect during treatment, including how to manage side effects and reduce infection risk.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

T-Cell Prolymphocytic Leukemia (T-PLL) — An Overview

Stem Cell Transplants for Leukemia